Analyze Diet
Osteoarthritis and cartilage2009; 18(1); 5-11; doi: 10.1016/j.joca.2009.07.005

The effects of oral glucosamine on joint health: is a change in research approach needed?

Abstract: Oral glucosamine (GlcN) has been widely studied for its potential therapeutic benefits in alleviating the pain and disability of osteoarthritis (OA). Its popularity has grown despite ongoing controversy regarding its effectiveness vs placebo in clinical trials, and lack of information regarding possible mechanisms of action. Here, we review the state of knowledge concerning the biology of GlcN as it relates to OA, and discuss a framework for future research directions. Methods: An editorial "narrative" review of peer-reviewed publications is organized into four topics (1) Chemistry and pharmacokinetics of GlcN salts (2) Biological effects of GlcN salts in vitro (3) Therapeutic effects of GlcN salts in animal models of OA and (4) GlcN salts in the treatment of clinical OA. Results: Data reporting potent pleiotropic activities of GlcN in in vitro cell and explant cultures are discussed in the context of the established pharmacokinetic data in humans and animals. The available clinical trial data are discussed to place the patient in the context of controlled research on disease management. Conclusions: Future research to determine therapeutic mechanisms of GlcN salt preparations will require use of standardized and clinically relevant in vitro assay systems and in vivo animal models for testing, as well as development of new outcome measures for inflammation and pain pathways in human OA.
Publication Date: 2009-09-01 PubMed ID: 19733270DOI: 10.1016/j.joca.2009.07.005Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article
  • Research Support
  • Non-U.S. Gov't
  • Review

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The study examined the potential benefits and shortcomings of glucosamine, a supplement often used for osteoarthritis management, and suggests areas that need further research to understand its therapeutic mechanisms.

Research Methodology

  • The methodology includes an editorial “narrative” review of peer-reviewed research articles. The review is organized into different modules: Glucosamine’s Chemistry and Pharmacokinetics, Biological Effects In Vitro, Therapeutic Effects in Animal Models, and Therapeutic Effects in Clinical Osteoarthritis.

Chemistry and Pharmacokinetics of Glucosamine Salts

  • The research provides insight into glucosamine’s chemical properties, including its pharmacokinetics–how the body absorbs, distributes, metabolizes, and excretes it. This is fundamental in understanding how glucosamine functions in the body once administered orally.

Biological Effects of Glucosamine Salts In Vitro

  • The research reviews glucosamine’s influence on cells in laboratory settings (in vitro). It’s important to comprehend these effects to hypothesize potential therapeutic mechanisms inside the body.

Therapeutic Effects of Glucosamine Salts in Animal Models of Osteoarthritis

  • The researchers reviewed studies that evaluated the therapeutic effects of glucosamine on animal models with osteoarthritis. This type of evaluation helps determine the potential benefits glucosamine might have on humans.

Glucosamine Salts in the Treatment of Clinical Osteoarthritis

  • The paper also reviews clinical trials where glucosamine was used in treating patients with osteoarthritis. Some controversies arise from these trials as findings on glucosamine’s effectiveness in alleviating pain and improving mobility vary.

Conclusions and Future Directions

  • Given the existing data, it’s seen that glucosamine possesses potent activities in in vitro cell cultures. The review suggests that further investigation is required on the active mechanisms of glucosamine in treating osteoarthritis.
  • Future research should utilize standardized and clinically relevant in vitro assays and in vivo animal models as testing grounds. There is also a call for developing new outcome measures to assess inflammation and pain pathways.

Cite This Article

APA
Block JA, Oegema TR, Sandy JD, Plaas A. (2009). The effects of oral glucosamine on joint health: is a change in research approach needed? Osteoarthritis Cartilage, 18(1), 5-11. https://doi.org/10.1016/j.joca.2009.07.005

Publication

ISSN: 1522-9653
NlmUniqueID: 9305697
Country: England
Language: English
Volume: 18
Issue: 1
Pages: 5-11

Researcher Affiliations

Block, J A
  • Department of Internal Medicine (Rheumatology), Rush University Medical Center, Chicago IL 60612, USA. jblock@rush.edu
Oegema, T R
    Sandy, J D
      Plaas, A

        MeSH Terms

        • Administration, Oral
        • Animals
        • Cattle
        • Dogs
        • Glucosamine / analogs & derivatives
        • Glucosamine / chemistry
        • Glucosamine / pharmacokinetics
        • Glucosamine / therapeutic use
        • Horses
        • Humans
        • Joints / drug effects
        • Osteoarthritis / drug therapy
        • Pain / drug therapy
        • Rabbits
        • Rats

        Citations

        This article has been cited 23 times.
        1. Derwich M, Górski B, Amm E, Pawłowska E. Oral Glucosamine in the Treatment of Temporomandibular Joint Osteoarthritis: A Systematic Review.. Int J Mol Sci 2023 Mar 3;24(5).
          doi: 10.3390/ijms24054925pubmed: 36902359google scholar: lookup
        2. Wang Z, Wang J, Zhang L, Meng X, Dai G, Wang Q. Diacerein plus glucosamine hydrochloride improves the safety and efficacy and inhibit inflammatory factors in the treatment of knee osteoarthritis.. Am J Transl Res 2023;15(1):548-555.
          pubmed: 36777840
        3. Allmeroth K, Hartman MD, Purrio M, Mesaros A, Denzel MS. Hexosamine pathway activation improves memory but does not extend lifespan in mice.. Aging Cell 2022 Oct;21(10):e13711.
          doi: 10.1111/acel.13711pubmed: 36124412google scholar: lookup
        4. Lambertini E, Penolazzi L, Pandolfi A, Mandatori D, Sollazzo V, Piva R. Human osteoclasts/osteoblasts 3D dynamic co‑culture system to study the beneficial effects of glucosamine on bone microenvironment.. Int J Mol Med 2021 Apr;47(4).
          doi: 10.3892/ijmm.2021.4890pubmed: 33604678google scholar: lookup
        5. Abdul Kadir A, Abdul Kadir A, Abd Hamid R, Mat Jais AM, Omar J, Sadagatullah AN, Badrin S, Win TT, Sirajudeen KNS, Salleh A. Evaluation of Chondroprotective Activity of Channa striatus in Rabbit Osteoarthritis Model.. Biomed Res Int 2019;2019:6979585.
          doi: 10.1155/2019/6979585pubmed: 31355276google scholar: lookup
        6. Li Y, Chen L, Liu Y, Zhang Y, Liang Y, Mei Y. Anti-inflammatory effects in a mouse osteoarthritis model of a mixture of glucosamine and chitooligosaccharides produced by bi-enzyme single-step hydrolysis.. Sci Rep 2018 Apr 4;8(1):5624.
          doi: 10.1038/s41598-018-24050-6pubmed: 29618773google scholar: lookup
        7. Byron CR, Trahan RA. Comparison of the Effects of Interleukin-1 on Equine Articular Cartilage Explants and Cocultures of Osteochondral and Synovial Explants.. Front Vet Sci 2017;4:152.
          doi: 10.3389/fvets.2017.00152pubmed: 28979900google scholar: lookup
        8. Wenz W, Hornung C, Cramer C, Schroeder M, Hoffmann M. Effect of Glucosamine Sulfate on Osteoarthritis in the Cruciate-Deficient Canine Model of Osteoarthritis.. Cartilage 2017 Apr;8(2):173-179.
          doi: 10.1177/1947603516638898pubmed: 28345412google scholar: lookup
        9. Sibbritt D, Lui C, Kroll T, Adams J. Prevalence of Glucosamine and Omega-3 Fatty Acid Use and Characteristics of Users among Mid-Age Women: Analysis of a Nationally Representative Sample of 10,638 Women.. J Nutr Health Aging 2016;20(6):637-44.
          doi: 10.1007/s12603-016-0721-2pubmed: 27273353google scholar: lookup
        10. Bascoul-Colombo C, Garaiova I, Plummer SF, Harwood JL, Caterson B, Hughes CE. Glucosamine Hydrochloride but Not Chondroitin Sulfate Prevents Cartilage Degradation and Inflammation Induced by Interleukin-1α in Bovine Cartilage Explants.. Cartilage 2016 Jan;7(1):70-81.
          doi: 10.1177/1947603515603762pubmed: 26958319google scholar: lookup
        11. Hrynets Y, Ndagijimana M, Betti M. Rapid Myoglobin Aggregation through Glucosamine-Induced α-Dicarbonyl Formation.. PLoS One 2015;10(9):e0139022.
          doi: 10.1371/journal.pone.0139022pubmed: 26406447google scholar: lookup
        12. Dodge GR, Regatte RR, Noyszewski EA, Hall JO, Sharma AV, Callaway DA, Reddy R. The Fate of Oral Glucosamine Traced by (13)C Labeling in the Dog.. Cartilage 2011 Jul;2(3):279-85.
          doi: 10.1177/1947603510391780pubmed: 26069586google scholar: lookup
        13. Provenza JR, Shinjo SK, Silva JM, Peron CR, Rocha FA. Combined glucosamine and chondroitin sulfate, once or three times daily, provides clinically relevant analgesia in knee osteoarthritis.. Clin Rheumatol 2015 Aug;34(8):1455-62.
          doi: 10.1007/s10067-014-2757-1pubmed: 25085275google scholar: lookup
        14. Kwoh CK, Roemer FW, Hannon MJ, Moore CE, Jakicic JM, Guermazi A, Green SM, Evans RW, Boudreau R. Effect of oral glucosamine on joint structure in individuals with chronic knee pain: a randomized, placebo-controlled clinical trial.. Arthritis Rheumatol 2014 Apr;66(4):930-9.
          doi: 10.1002/art.38314pubmed: 24616448google scholar: lookup
        15. Henrotin Y, Lambert C. Chondroitin and glucosamine in the management of osteoarthritis: an update.. Curr Rheumatol Rep 2013 Oct;15(10):361.
          doi: 10.1007/s11926-013-0361-zpubmed: 23955063google scholar: lookup
        16. Caramés B, Kiosses WB, Akasaki Y, Brinson DC, Eap W, Koziol J, Lotz MK. Glucosamine activates autophagy in vitro and in vivo.. Arthritis Rheum 2013 Jul;65(7):1843-52.
          doi: 10.1002/art.37977pubmed: 23606170google scholar: lookup
        17. Henrotin Y, Chevalier X, Herrero-Beaumont G, McAlindon T, Mobasheri A, Pavelka K, Schön C, Weinans H, Biesalski H. Physiological effects of oral glucosamine on joint health: current status and consensus on future research priorities.. BMC Res Notes 2013 Mar 26;6:115.
          doi: 10.1186/1756-0500-6-115pubmed: 23531101google scholar: lookup
        18. Sibbritt D, Adams J, Lui CW, Broom A, Wardle J. Who uses glucosamine and why? A study of 266,848 Australians aged 45 years and older.. PLoS One 2012;7(7):e41540.
          doi: 10.1371/journal.pone.0041540pubmed: 22859995google scholar: lookup
        19. Rovati LC, Girolami F, Persiani S. Crystalline glucosamine sulfate in the management of knee osteoarthritis: efficacy, safety, and pharmacokinetic properties.. Ther Adv Musculoskelet Dis 2012 Jun;4(3):167-80.
          doi: 10.1177/1759720X12437753pubmed: 22850875google scholar: lookup
        20. Henrotin Y, Mobasheri A, Marty M. Is there any scientific evidence for the use of glucosamine in the management of human osteoarthritis?. Arthritis Res Ther 2012 Jan 30;14(1):201.
          doi: 10.1186/ar3657pubmed: 22293240google scholar: lookup
        21. Chiusaroli R, Piepoli T, Zanelli T, Ballanti P, Lanza M, Rovati LC, Caselli G. Experimental pharmacology of glucosamine sulfate.. Int J Rheumatol 2011;2011:939265.
          doi: 10.1155/2011/939265pubmed: 22007227google scholar: lookup
        22. Jerosch J. Effects of Glucosamine and Chondroitin Sulfate on Cartilage Metabolism in OA: Outlook on Other Nutrient Partners Especially Omega-3 Fatty Acids.. Int J Rheumatol 2011;2011:969012.
          doi: 10.1155/2011/969012pubmed: 21826146google scholar: lookup
        23. Jackson CG, Plaas AH, Sandy JD, Hua C, Kim-Rolands S, Barnhill JG, Harris CL, Clegg DO. The human pharmacokinetics of oral ingestion of glucosamine and chondroitin sulfate taken separately or in combination.. Osteoarthritis Cartilage 2010 Mar;18(3):297-302.
          doi: 10.1016/j.joca.2009.10.013pubmed: 19912983google scholar: lookup